Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
FELE$98.07-0.54(-0.55%)Franklin Electric Enters Into Agreement to Acquire Challenge Pumps, Strengthening Global Mineral Extraction Dewatering Platform[7:33:14 PM ET]ELEK$0.00-0.00(-4.88%)The American Lithium Advantage: Elektros Eyes a New Frontier on U.S. Soil[7:25:00 PM ET]LVS$36.01-0.56(-1.54%)SANDS CHINA ANNOUNCES PRICING OF $1.0 BILLION OF SENIOR UNSECURED NOTES Las Vegas Sands Corp. (NYSE: LVS) today announced that its majority-owned subsidiary, Sands China Ltd. ("Sands China"), has priced $700 million of...[7:23:00 PM ET]UWMC$1.57+0.16(+11.35%)Lifshitz Law PLLC Announces Investigations of UWM Holdings Corporation (NYSE: UWMC), The Simply Good Foods Company (NASDAQ: SMPL), Aardvark Therapeutics, Inc. (NASDAQ: AARD), and Floteck Industries, Inc. (NASDAQ: FTK)[7:03:00 PM ET]BETR$20.26+2.54(+14.33%)Better 2.0 Publishes Weekly Scorecard, Week 3: Mortgage Operations and Corporate Efficiency[7:02:00 PM ET]AJG$259.01-7.78(-2.92%)Arthur J. Gallagher & Co. Announces Regular Fourth Quarter Dividend Arthur J. Gallagher & Co. (NYSE: AJG) today declared a regular quarterly cash dividend of seventy cents ($0.70) per share on the Common Stock of the...[7:00:00 PM ET]GRLVF$0.51+0.03(+6.53%)Group Eleven Announces Issuance of Stock Options and DSUs[7:00:00 PM ET]EONR$0.40-0.02(-5.23%)EON Resources Inc. Provides FAQ Responses in Advance of Earnings Call[6:55:00 PM ET]PDS$99.96+1.16(+1.17%)Precision Drilling Announces 2026 Third Quarter Unaudited Financial Statements[6:42:54 PM ET]TAC$13.50+1.23(+10.02%)TransAlta Declares Dividends[6:40:57 PM ET]GTERU$10.57+0.19(+1.83%)Globa Terra Acquisition Corporation Reports Encouraging Investor Support Ahead of November 9 Extension Vote[6:30:00 PM ET]LU$8.50+0.02(+0.24%)Lufax Reports Third Quarter 2026 Financial Results Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China,...[6:30:00 PM ET]AMGN$451.95+7.32(+1.65%)AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the fourth quarter of 2026. The dividend...[6:27:00 PM ET]GAMXF$0.05+0.01(+25.20%)Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options[6:25:00 PM ET]CBRE$121.65-1.23(-1.00%)CBRE Group, Inc. Announces Pricing of $500 Million Senior Notes due 2032 and $500 Million Senior Notes due 2037[6:21:00 PM ET]

ERAS · NASDAQ

Erasca, Inc.

$15.10 +0.11 (+0.73%)

Company overview

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$5.3B
Employees
103
Headquarters
San Diego, CA
Website
erasca.com
CEO
Jonathan E. Lim
Listed
July 16, 2021
P/E
-16.24
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$1.5M
Operating income
-$143M
EBITDA
-$129M
Net income
-$277M
EPS
-$0.93
Total assets
$461M
Total debt
$46M
Earnings yield
-6.16%

Price chart

8.0812.2816.4920.7024.90
ERAS 1D NASDAQ O14.58H15.47L14.55C14.99+0.60 (+4.17%)Vol6.47M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
ERASErasca, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Erasca, Inc. - ERAS GlobeNewswire
ERASErasca, Inc. Legal Important Notice Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Power Solutions International, Inc. GlobeNewswire
ERASErasca, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS ACCESS Newswire
ERASErasca, Inc. Legal ERAS Investors with $100,000 in Losses Have Opportunity to Join Erasca, Inc. Fraud Investigation with SBS Law Business Wire
ERASErasca, Inc. Legal Important Notice to Long-Term Shareholders of Coastal Financial Corporation (NASDAQ: CCB); D-Wave Quantum Inc. (NASDAQ: QBTS); Erasca, Inc. (NASDAQ: ERAS) and Planet Fitness, Inc. GlobeNewswire
ERASErasca, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS PRNewsWire
ERASErasca, Inc. Legal Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); and New Era Energy & Digital, Inc. GlobeNewswire
ERASErasca, Inc. Legal Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Bank of America Corporation (NYSE: BAC); Coastal Financial Corporation (NASDAQ: CCB); and Erasca, Inc. GlobeNewswire
ERASErasca, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS ACCESS Newswire
ERASErasca, Inc. Stock news Erasca (NASDAQ:ERAS) Shares Down 5.8% – What’s Next? Defense World
ERASErasca, Inc. Legal Bronstein, Gewirtz & Grossman, LLC Encourages Erasca, Inc. (ERAS) Stockholders to Inquire about Securities Investigation ACCESS Newswire
ERASErasca, Inc. Legal Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and Power Solutions International, Inc. GlobeNewswire
ERASErasca, Inc. Legal Important Notice to Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS) and Planet Fitness, Inc. GlobeNewswire
ERASErasca, Inc. Legal Attention Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire
ERASErasca, Inc. Stock news Erasca: Revolution's Approval Just Took Risk Out Of The Fast Follower Seeking Alpha
ERASErasca, Inc. Stock news Erasca, Inc. (NASDAQ:ERAS) Stock Has Consensus Target Price of $22.09 Defense World
ERASErasca, Inc. Press release Important Notice to Long-Term Shareholders of Beta Bionics, GlobeNewswire
ERASErasca, Inc. Press release Important Notice to Long-Term Shareholders of Doximity, GlobeNewswire
ERASErasca, Inc. Legal ERASCA, INC. (NASDAQ: ERAS) SHAREHOLDER INVESTIGATION GlobeNewswire
ERASErasca, Inc. Press release Propanc Biopharma Highlights Differentiated PRP Pancreatic GlobeNewswire
See more
FAQ

Questions about Erasca, Inc.

What does Erasca, Inc. do?
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
What is ERAS's market cap?
Erasca, Inc. (ERAS) is a listed stock with a live quote. The latest market cap on this page is $5.3B.
Where is Erasca, Inc. headquartered?
Erasca, Inc. is headquartered in San Diego, CA.
How do I get ERAS news from the API?
Call GET /v1/news?tickers=ERAS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does ERAS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ERAS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the ERAS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs